Literature DB >> 24174660

Modulation of NMDAR subunit expression by TRPM2 channels regulates neuronal vulnerability to ischemic cell death.

Ishraq Alim1, Lucy Teves, Rongwen Li, Yasuo Mori, Michael Tymianski.   

Abstract

Neuronal vulnerability to ischemia is dependent on the balance between prosurvival and prodeath cellular signaling. In the latter, it is increasingly appreciated that toxic Ca(2+) influx can occur not only via postsynaptic glutamate receptors, but also through other cation conductances. One such conductance, the Transient receptor potential melastatin type-2 (TRPM2) channel, is a nonspecific cation channel having homology to TRPM7, a conductance reported to play a key role in anoxic neuronal death. The role of TRPM2 conductances in ischemic Ca(2+) influx has been difficult to study because of the lack of specific modulators. Here we used TRPM2-null mice (TRPM2(-/-)) to study how TRPM2 may modulate neuronal vulnerability to ischemia. TRPM2(-/-) mice subjected to transient middle cerebral artery occlusion exhibited smaller infarcts when compared with wild-type animals, suggesting that the absence of TRPM2 is neuroprotective. Surprisingly, field potentials (fEPSPs) recorded during redox modulation in brain slices taken from TRPM2(-/-) mice revealed increased excitability, a phenomenon normally associated with ischemic vulnerability, whereas wild-type fEPSPs were unaffected. The upregulation in fEPSP in TRPM2(-/-) neurons was blocked selectively by a GluN2A antagonist. This increase in excitability of TRPM2(-/-) fEPSPs during redox modulation depended on the upregulation and downregulation of GluN2A- and GluN2B-containing NMDARs, respectively, and on augmented prosurvival signaling via Akt and ERK pathways culminating in the inhibition of the proapoptotic factor GSK3β. Our results suggest that TRPM2 plays a role in downregulating prosurvival signals in central neurons and that TRPM2 channels may comprise a therapeutic target for preventing ischemic damage.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24174660      PMCID: PMC6618359          DOI: 10.1523/JNEUROSCI.1729-13.2013

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  40 in total

1.  Characterization and Optimization of the Novel Transient Receptor Potential Melastatin 2 Antagonist tatM2NX.

Authors:  I Cruz-Torres; D S Backos; P S Herson
Journal:  Mol Pharmacol       Date:  2019-11-26       Impact factor: 4.436

Review 2.  Role of TRPM7 in cerebral ischaemia and hypoxia.

Authors:  Hong-Shuo Sun
Journal:  J Physiol       Date:  2017-02-08       Impact factor: 5.182

Review 3.  Detrimental or beneficial: the role of TRPM2 in ischemia/reperfusion injury.

Authors:  Kai-yu Zhan; Pei-lin Yu; Chun-hui Liu; Jian-hong Luo; Wei Yang
Journal:  Acta Pharmacol Sin       Date:  2016-01       Impact factor: 6.150

4.  TRPM4 activation by chemically- and oxygen deprivation-induced ischemia and reperfusion triggers neuronal death.

Authors:  Elías Leiva-Salcedo; Denise Riquelme; Oscar Cerda; Andrés Stutzin
Journal:  Channels (Austin)       Date:  2017-10-05       Impact factor: 2.581

Review 5.  Pannexin channels and ischaemia.

Authors:  Roger J Thompson
Journal:  J Physiol       Date:  2014-12-02       Impact factor: 5.182

Review 6.  Mouse models of Down syndrome: gene content and consequences.

Authors:  Meenal Gupta; A Ranjitha Dhanasekaran; Katheleen J Gardiner
Journal:  Mamm Genome       Date:  2016-08-18       Impact factor: 2.957

7.  TRPM2 Channel Aggravates CNS Inflammation and Cognitive Impairment via Activation of Microglia in Chronic Cerebral Hypoperfusion.

Authors:  Jun Miyanohara; Masashi Kakae; Kazuki Nagayasu; Takayuki Nakagawa; Yasuo Mori; Ken Arai; Hisashi Shirakawa; Shuji Kaneko
Journal:  J Neurosci       Date:  2018-03-09       Impact factor: 6.167

8.  Reversal of Global Ischemia-Induced Cognitive Dysfunction by Delayed Inhibition of TRPM2 Ion Channels.

Authors:  Robert M Dietz; Ivelisse Cruz-Torres; James E Orfila; Olivia P Patsos; Kaori Shimizu; Nicholas Chalmers; Guiying Deng; Erika Tiemeier; Nidia Quillinan; Paco S Herson
Journal:  Transl Stroke Res       Date:  2019-06-28       Impact factor: 6.829

9.  Waixenicin A, a marine-derived TRPM7 inhibitor: a promising CNS drug lead.

Authors:  Hong-Shuo Sun; F David Horgen; Daniel Romo; Kenneth G Hull; Sigrid A Kiledal; Andrea Fleig; Zhong-Ping Feng
Journal:  Acta Pharmacol Sin       Date:  2020-09-29       Impact factor: 6.150

10.  P450 Eicosanoids and Reactive Oxygen Species Interplay in Brain Injury and Neuroprotection.

Authors:  Xuehong Liu; Catherine M Davis; Nabil J Alkayed
Journal:  Antioxid Redox Signal       Date:  2017-04-20       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.